Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10155806 Antibody molecules to dengue virus and uses thereof

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Luke Robinson0

Gregory Babcock0

James R. Myette0

Karthik Viswanathan0

Zachary Shriver0

Date of Patent

December 18, 2018

0

Patent Application Number

151556200

Date Filed

May 16, 2016

0

Patent Citations Received

0

US Patent 11534487 Cross-immunizing antigen vaccine and method for preparation thereof

US Patent 11576962 Cross-immunizing antigen vaccine and method for preparation thereof

US Patent 11059883 Antibody molecules to dengue virus and uses thereof

US Patent 11918651 Formulations of antibody molecules to dengue virus

0

Patent Primary Examiner

0

Patent abstract

Antibody molecules that specifically bind to dengue virus are disclosed. In certain embodiments, the antibody molecule bind to dengue virus serotypes DV-1, DV-2, DV-3, and DV-4. The antibody molecules can be used to treat, prevent, and/or diagnose dengue virus.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10155806 Antibody molecules to dengue virus and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool